Going up?
Me, I’m going down. My A1C is under 7%.*
true
Eric Stonestreet and his mom, Jamey, take Mounjaro for type 2 diabetes. All others are paid actors.
Paid partnership with Lilly.
Lilly works with leading health and patient advocacy organizations to improve care for people living with type 2 diabetes.
Paid partnership with Lilly.
Lilly works with leading health and patient advocacy organizations to improve care for people living with type 2 diabetes.
true
ON THIS PAGE
Mounjaro results
Mounjaro results
Mounjaroresults
Why Mounjaro
Why Mounjaro
whymounjaro
backgroundOption
color
backgroundColor
background-none
textColor
auto
additionalPadding
none
additionalMargin
none
4
3
backgroundOption
color
backgroundColor
background-none
textColor
auto
additionalPadding
none
additionalMargin
none
_*Up to 90% of adults taking Mounjaro reached an A1C under 7%._
In studies with or without other diabetes medications, 75% (5mg) to 90% (10mg) of adults taking Mounjaro reached an A1C <7%. Average starting A1C was 7.9% to 8.6% across the 5-, 10-, 15-mg doses. In a study of basal insulin with or without Mounjaro, 90% of adults taking Mounjaro 10 mg with basal insulin reached A1C <7% vs basal insulin alone.
Mounjaro is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults and children 10 years of age and older with type 2 diabetes mellitus. It is not known if Mounjaro is safe and effective for use in children under 10 years of age.
Select Safety Information
Warning
Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, Mounjaro and medicines that work like Mounjaro caused thyroid tumors, including thyroid cancer. It is not known if Mounjaro will cause thyroid tumors, or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Do not take Mounjaro if you or any of your family have ever had MTC or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Mounjaro is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults and children 10 years of age and older with type 2 diabetes mellitus. It is not known if Mounjaro is safe and effective for use in children under 10 years of age.
Select Safety Information
Warning
Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rats, Mounjaro and medicines that work like Mounjaro caused thyroid tumors, including thyroid cancer. It is not known if Mounjaro will cause thyroid tumors, or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Do not take Mounjaro if you or any of your family have ever had MTC or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
_Adults taking Mounjaro lost up to 25 lbs†_
†Mounjaro is not a weight loss drug.
Individual results may vary. In the same studies with or without other diabetes medications, weight loss in adults ranged from 12 lb (5 mg) to 25 lb (15 mg).
Individual results may vary. In the same studies with or without other diabetes medications, weight loss in adults ranged from 12 lb (5 mg) to 25 lb (15 mg).
0
0
Select Safety Information
Do not use Mounjaro if you or any of your family have ever had a type of thyroid cancer called MTC or if you have an endocrine system condition called MEN 2, or if you have had a serious allergic reaction to tirzepatide or any of the ingredients in Mounjaro.
Do not use Mounjaro if you or any of your family have ever had a type of thyroid cancer called MTC or if you have an endocrine system condition called MEN 2, or if you have had a serious allergic reaction to tirzepatide or any of the ingredients in Mounjaro.
text
Mounjaroresults
backgroundOption
color
backgroundColor
background-none
style
desktop-background-none, mobile-background-none, backgroundcolorcolumn1-surface-2, backgroundcolorcolumn2-surface-4, backgroundcolorcolumn3-none, backgroundcolorcolumn4-none, align-stretch, inner-color, two-col-50-50
textColor
auto
additionalPadding
none
additionalMargin
none
roundedBorderscolumncontainer
true
4
3
backgroundOption
color
backgroundColor
background-none
textColor
auto
additionalPadding
none
additionalMargin
none
true
_Why Mounjaro?_
Eric didn’t understand the magnitude of type 2 diabetes when he was first diagnosed.
Three years ago, after trying different treatments and not reaching his A1C goal, Eric’s doctor told him about Mounjaro.
With Mounjaro, along with diet and exercise, he’s been able to lower his A1C. Eric also told his mom, Jamey, to talk to her doctor about it. Now Jamey’s using Mounjaro too. But Eric and Jamey don’t just rely on Mounjaro: they try to maintain a healthy lifestyle as well.
By partnering with Lilly, they’re hoping to inspire others with type 2 diabetes to talk to their doctors about treatment options that are right for them.
How is Mounjaro different? See how it compares to some other type 2 diabetes medications like Ozempic.
Three years ago, after trying different treatments and not reaching his A1C goal, Eric’s doctor told him about Mounjaro.
With Mounjaro, along with diet and exercise, he’s been able to lower his A1C. Eric also told his mom, Jamey, to talk to her doctor about it. Now Jamey’s using Mounjaro too. But Eric and Jamey don’t just rely on Mounjaro: they try to maintain a healthy lifestyle as well.
By partnering with Lilly, they’re hoping to inspire others with type 2 diabetes to talk to their doctors about treatment options that are right for them.
How is Mounjaro different? See how it compares to some other type 2 diabetes medications like Ozempic.
0
0
text
whymounjaro
backgroundOption
color
backgroundColor
background-none
style
desktop-background-none, mobile-background-none, backgroundcolorcolumn1-none, backgroundcolorcolumn2-none, backgroundcolorcolumn3-none, backgroundcolorcolumn4-none, align-stretch, inner-color, two-col-33-66
textColor
auto
additionalPadding
none
additionalMargin
none
4
3
backgroundOption
color
backgroundColor
background-none
textColor
auto
additionalPadding
none
additionalMargin
none
Paid partnership with Lilly. Eric Stonestreet and his mom Jamey take Mounjaro for type 2 diabetes.
Ozempic® is a registered trademark of Novo Nordisk A/S.
backgroundOption
color
backgroundColor
background-none
textColor
auto
additionalPadding
none
additionalMargin
none